Vadodara: Alembic Pharma has announced the resignation of Viraj Save, Executive Vice President – Sales and Marketing from his position.
“We would like to inform that Mr. Viraj Save, Executive Vice President –Sales and Marketing has resigned from the said position and relieved w.e.f. 31st May, 2025,” Alembic informed in a BSE filing.
Viraj is a sales and marketing professional over 30 years of experience in Indian Pharmaceutical Industry with proven track record in business management and having therapy expertise in Cardiology, Critical Cardiology , Diabetes (Oral hypogyceimic agents & Diabetes specific Nutrition), Clinical Nutrition, Pain Management, and Dermacare
Viraj Save joined Alembic in 2022 as Sr. Vice President Sales & Marketing. Prior to this, he worked at Emcure Pharma as Executive Vice President – Sales and Marketing. He also served Abbott Nutrition NL, Abbott, Ipca Labs and Lupin.
Read also: Alembic Pharma bags USFDA okay for blood cancer drug Bosutinib
Headquartered in India, Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company. It is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic’s state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.
Read also: USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year
